SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001362310-08-002591
Filing Date
2008-05-09
Accepted
2008-05-08 19:54:08
Documents
6
Period of Report
2008-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c73267e10vq.htm 10-Q 339352
2 EXHIBIT 10.1 c73267exv10w1.htm EX-10.1 10784
3 EXHIBIT 10.2 c73267exv10w2.htm EX-10.2 11280
4 EXHIBIT 31.1 c73267exv31w1.htm EX-31.1 8706
5 EXHIBIT 31.2 c73267exv31w2.htm EX-31.2 8974
6 EXHIBIT 32.1 c73267exv32w1.htm EX-32.1 4931
  Complete submission text file 0001362310-08-002591.txt   385617
Mailing Address 150 INDUSTRIAL ROAD SAN CARLOS CA 94070
Business Address 150 INDUSTRIAL RD SAN CARLOS CA 94070 6506313100
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24006 | Film No.: 08815668
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1